(Q47771309)

English

The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer. (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

1 reference

based on heuristic

inferred from title

author name string

Tzong-Shin Tzai

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

Yuh-Shyan Tsai

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

Nan-Haw Chow

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

publication date

1 March 2004

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

Urologic Oncology

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

22

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

112-118

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a)

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2803%2900176-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1078-1439(03)00176-5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15082007

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47771309&oldid=1414965619"